Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer Academic Article uri icon


MeSH Major

  • Adenocarcinoma
  • Gene Expression Regulation, Neoplastic
  • Isoenzymes
  • Pancreatic Neoplasms
  • Prostaglandin-Endoperoxide Synthases
  • Transcription, Genetic


  • A large body of evidence suggests that cyclooxygenase-2 (COX-2) is important in gastrointestinal cancer. The purpose of this study was to determine whether COX-2 was expressed in adenocarcinoma of the human pancreas. Quantitative reverse transcription-PCR, immunoblotting, and immunohistochemistry were used to assess the expression of COX-2 in pancreatic tissue. Levels of COX-2 mRNA were increased by >60-fold in pancreatic cancer compared to adjacent nontumorous tissue. COX-2 protein was present in 9 of 10 cases of adenocarcinoma of the pancreas but was undetectable in nontumorous pancreatic tissue. Immunohistochemical analysis showed that COX-2 was expressed in malignant epithelial cells. In cultured human pancreatic cancer cells, levels of COX-2 mRNA and protein were induced by treatment with tumor-promoting phorbol esters. Taken together, these results suggest that COX-2 may be a target for the prevention or treatment of pancreatic cancer.

publication date

  • March 1999



  • Academic Article



  • eng

PubMed ID

  • 10070951

Additional Document Info

start page

  • 987

end page

  • 90


  • 59


  • 5